1: Sastre D, Colomer-Molera M, de Benito-Bueno A, Valenzuela C, Fernández- Ballester G, Felipe A. KCNE4-dependent modulation of Kv1.3 pharmacology. Biochem Pharmacol. 2024 Aug;226:116368. doi: 10.1016/j.bcp.2024.116368. Epub 2024 Jun 14. PMID: 38880360.
2: Schilardi G, Kralik J, Kleinlogel S. Selective Block of Upregulated Kv1.3 Potassium Channels in ON-Bipolar Cells of the Blind Retina Enhances Optogenetically Restored Signaling. Int J Mol Sci. 2023 Sep 18;24(18):14207. doi: 10.3390/ijms241814207. PMID: 37762510; PMCID: PMC10531754.
3: Sala C, Staderini M, Lottini T, Duranti C, Angelini G, Constantin G, Arcangeli A. Expression of the ether-a-gò-gò-related gene 1 channel during B and T lymphocyte development: role in BCR and TCR signaling. Front Immunol. 2023 Sep 8;14:1111471. doi: 10.3389/fimmu.2023.1111471. PMID: 37744334; PMCID: PMC10515723.
4: Labbaf A, Dellin M, Komadowski M, Chetkovich DM, Decher N, Pape HC, Seebohm G, Budde T, Zobeiri M. Characterization of Kv1.2-mediated outward current in TRIP8b-deficient mice. Biol Chem. 2023 Mar 1;404(4):291-302. doi: 10.1515/hsz-2023-0116. PMID: 36852869.
5: Chen YJ, Cui Y, Singh L, Wulff H. The potassium channel Kv1.3 as a therapeutic target for immunocytoprotection after reperfusion. Ann Clin Transl Neurol. 2021 Oct;8(10):2070-2082. doi: 10.1002/acn3.51456. Epub 2021 Oct 7. PMID: 34617690; PMCID: PMC8528456.
6: Admasu TD, Barardo D, Ng LF, Batchu KC, Cazenave-Gassiot A, Wenk MR, Gruber J. A small-molecule Psora-4 acts as a caloric restriction mimetic to promote longevity in C. elegans. Geroscience. 2022 Apr;44(2):1029-1046. doi: 10.1007/s11357-021-00374-6. Epub 2021 May 14. PMID: 33988831; PMCID: PMC9135947.
7: Montalbano A, Sala C, Abrardo C, Murciano N, Jahanfar F, D'Amico M, Bertoni F, Becchetti A, Arcangeli A. Data describing the effects of potassium channels modulators on outward currents measured in human lymphoma cell lines. Data Brief. 2020 Dec 21;34:106668. doi: 10.1016/j.dib.2020.106668. PMID: 33385031; PMCID: PMC7772536.
8: Lang Y, Li F, Liu Q, Xia Z, Ji Z, Hu J, Cheng Y, Gao M, Sun F, Shen B, Xie C, Yi W, Wu Y, Yao J, Cao Z. The Kv1.3 ion channel acts as a host factor restricting viral entry. FASEB J. 2021 Feb;35(2):e20995. doi: 10.1096/fj.202000879RR. Epub 2020 Sep 10. PMID: 32910509.
9: Mei Y, Fang C, Ding S, Liu X, Hu J, Xu J, Mei Q. PAP-1 ameliorates DSS- induced colitis with involvement of NLRP3 inflammasome pathway. Int Immunopharmacol. 2019 Oct;75:105776. doi: 10.1016/j.intimp.2019.105776. Epub 2019 Jul 24. PMID: 31351364.
10: Admasu TD, Batchu KC, Ng LF, Cazenave-Gassiot A, Wenk MR, Gruber J. Lipid profiling of C. elegans strains administered pro-longevity drugs and drug combinations. Sci Data. 2018 Oct 23;5:180231. doi: 10.1038/sdata.2018.231. PMID: 30351306; PMCID: PMC6198751.
11: Admasu TD, Chaithanya Batchu K, Barardo D, Ng LF, Lam VYM, Xiao L, Cazenave- Gassiot A, Wenk MR, Tolwinski NS, Gruber J. Drug Synergy Slows Aging and Improves Healthspan through IGF and SREBP Lipid Signaling. Dev Cell. 2018 Oct 8;47(1):67-79.e5. doi: 10.1016/j.devcel.2018.09.001. Epub 2018 Sep 27. PMID: 30269951.
12: Maezawa I, Nguyen HM, Di Lucente J, Jenkins DP, Singh V, Hilt S, Kim K, Rangaraju S, Levey AI, Wulff H, Jin LW. Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer's disease: preclinical proof of concept. Brain. 2018 Feb 1;141(2):596-612. doi: 10.1093/brain/awx346. PMID: 29272333; PMCID: PMC5837198.
13: Venturini E, Leanza L, Azzolini M, Kadow S, Mattarei A, Weller M, Tabatabai G, Edwards MJ, Zoratti M, Paradisi C, Szabò I, Gulbins E, Becker KA. Targeting the Potassium Channel Kv1.3 Kills Glioblastoma Cells. Neurosignals. 2017;25(1):26-38. doi: 10.1159/000480643. Epub 2017 Sep 1. PMID: 28869943.
14: Kidd MW, Bulley S, Jaggar JH. Angiotensin II reduces the surface abundance of KV 1.5 channels in arterial myocytes to stimulate vasoconstriction. J Physiol. 2017 Mar 1;595(5):1607-1618. doi: 10.1113/JP272893. Epub 2017 Feb 5. PMID: 27958660; PMCID: PMC5330887.
15: Nishijima Y, Cao S, Chabowski DS, Korishettar A, Ge A, Zheng X, Sparapani R, Gutterman DD, Zhang DX. Contribution of KV1.5 Channel to Hydrogen Peroxide-Induced Human Arteriolar Dilation and Its Modulation by Coronary Artery Disease. Circ Res. 2017 Feb 17;120(4):658-669. doi: 10.1161/CIRCRESAHA.116.309491. Epub 2016 Nov 21. PMID: 27872049; PMCID: PMC5315616.
16: Zhou YY, Hou GQ, He SW, Xiao Z, Xu HJ, Qiu YT, Jiang S, Zheng H, Li ZY. Psora-4, a Kv1.3 Blocker, Enhances Differentiation and Maturation in Neural Progenitor Cells. CNS Neurosci Ther. 2015 Jul;21(7):558-67. doi: 10.1111/cns.12402. Epub 2015 May 15. PMID: 25976092; PMCID: PMC6495590.
17: Ueyama A, Imura K, Kasai-Yamamoto E, Tai N, Nagira M, Shichijo M, Yasui K. Kv1.3 blockers ameliorate allergic contact dermatitis by preferentially suppressing effector memory T cells in a rat model. Clin Exp Dermatol. 2013 Dec;38(8):897-903. doi: 10.1111/ced.12097. PMID: 24252082.
18: Hamilton DL, Beall C, Jeromson S, Chevtzoff C, Cuthbertson DJ, Ashford ML. Kv1.3 inhibitors have differential effects on glucose uptake and AMPK activity in skeletal muscle cell lines and mouse ex vivo skeletal muscle. J Physiol Sci. 2014 Jan;64(1):13-20. doi: 10.1007/s12576-013-0285-4. Epub 2013 Sep 17. PMID: 24043354; PMCID: PMC10717203.
19: Wulff H, Yarov-Yarovoy V. Channels: Sticking to nooks and crannies. Nat Chem Biol. 2013 Aug;9(8):473-4. doi: 10.1038/nchembio.1292. PMID: 23868316.
20: Marzian S, Stansfeld PJ, Rapedius M, Rinné S, Nematian-Ardestani E, Abbruzzese JL, Steinmeyer K, Sansom MS, Sanguinetti MC, Baukrowitz T, Decher N. Side pockets provide the basis for a new mechanism of Kv channel-specific inhibition. Nat Chem Biol. 2013 Aug;9(8):507-13. doi: 10.1038/nchembio.1271. Epub 2013 Jun 2. PMID: 23728494; PMCID: PMC4539245.